1. Khalikova E.Yu. Safety and efficacy of HES in infusion therapy programs. Trudnyi patsient. 2012;10(5):22-29. (In Russian)
2. Pustovoit VL, Dobrokhotov DA, Nesterova NV. Hydroxyethyl starch as an alternative colloidal blood substitute of the coarse nature of modern clinical practice. In: Open Innovation: Trudy VIII Mezhdunarodnoi nauchno-prakticheskoi konferentsii = Open Innovation: Proceedings of VIII International Scientific and Practical Conference. Penza, 23 April 2019. Penza: Nauka i Prosveshchenie, 2019, pp. 272-276. (In Russian)
3. Giordano G, Pugliese F, Bilotta F. Hydroxyethyl starch and fluid challenge. European Journal of Anaesthesiology. 2020;37(7):611-621. https://doi.org/10.1097/EJA.0000000000001147
4. Traven VF, Panov AV, Dolotov SM, Strelnikova TA, Suslov VV, Gladyrev VV. Comparative analysis of potato and corn starch hydroxyethylation products by gas-liquid chromatography and 13C NMR spectroscopy. Khimija rastitel'nogo syrja = Chemistry of plant raw material. 2009;3:57-61. (In Russian)
5. Sukhotin SK. Possibilities of plasma-substituting solutions of hydroxyethylated starch (HES) in resuscitation and surgery. Refortan®, Refortan® plus, Stabizol®. Dal'nevostochnyi meditsinskii zhurnal. 2001;S4:68-72. (In Russian)